Australia markets closed

OncoCyte Corporation (OCX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.9300-0.1200 (-3.93%)
At close: 04:00PM EDT
2.8200 -0.11 (-3.75%)
After hours: 06:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate-0.51-0.49-2.28-1.71
Low estimate-0.72-0.7-2.84-2.61
High estimate-0.37-0.35-1.57-0.89
Year ago EPS-1.07-0.81-3.75-2.28
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate400k530k1.83M5.9M
Low estimate300k300k1.1M2.61M
High estimate500k800k2.6M8.5M
Year ago sales463kN/A1.5M1.83M
Sales growth (year/est)-13.60%N/A21.80%222.40%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.3-1.01-1.14-0.67
Actual EPS-1.07-0.81-2.12-1.13
Difference0.230.2-0.98-0.46
Surprise %17.70%19.80%-86.00%-68.70%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.51-0.49-2.28-1.71
7 days ago-0.6-0.58-2.39-1.98
30 days ago-0.65-0.58-2.95-2.52
60 days ago-0.61-0.51-3.01-2.43
90 days ago-0.61-0.51-3.01-2.43
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days1111
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesOCXIndustrySector(s)S&P 500
Current qtr.52.30%N/AN/AN/A
Next qtr.39.50%N/AN/AN/A
Current year39.20%N/AN/AN/A
Next year25.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A